The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy c
SMi Reports: This year’s Immuno-Oncology conference, taking place 26th - 27th September in London, aims to address the issues and challenges burdening the industry, as well as the promising advance
Lonza has boosted its ability to cater for customers in the fast-emerging antibody-drug conjugate category with a deal to buy Dutch company Synaffix and its platform techn
